Cargando…

Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy

SIMPLE SUMMARY: Tumor necrosis factor (TNF) receptor-2 (TNFR2) affects tumor development and metastasis in several ways. TNFR2 promotes tumor immune escape by virtue of its ability to stimulate various immune suppressive cell types, e.g., regulatory T-cells (Tregs) and myeloid-derived suppressor cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Medler, Juliane, Kucka, Kirstin, Wajant, Harald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179537/ https://www.ncbi.nlm.nih.gov/pubmed/35681583 http://dx.doi.org/10.3390/cancers14112603

Ejemplares similares

Membrane lymphotoxin-α(2)β is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist
por: Kucka, Kirstin, et al.
Publicado: (2021)

Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor Superfamily
por: Kucka, Kirstin, et al.
Publicado: (2021)

Activation of TNFR2 sensitizes macrophages for TNFR1-mediated necroptosis
por: Siegmund, Daniela, et al.
Publicado: (2016)

TNFR1 and TNFR2 in the Control of the Life and Death Balance of Macrophages
por: Wajant, Harald, et al.
Publicado: (2019)

Fn14 and TNFR2 as regulators of cytotoxic TNFR1 signaling
por: Siegmund, Daniela, et al.
Publicado: (2023)

TNFR2 unlocks a RIPK1 kinase activity-dependent mode of proinflammatory TNFR1 signaling
por: Siegmund, Daniela, et al.
Publicado: (2018)

Lack of Evidence for a Direct Interaction of Progranulin and Tumor Necrosis Factor Receptor-1 and Tumor Necrosis Factor Receptor-2 From Cellular Binding Studies
por: Lang, Isabell, et al.
Publicado: (2018)

Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily
por: Zaitseva, Olena, et al.
Publicado: (2023)

CD40- and 41BB-specific antibody fusion proteins with PDL1 blockade-restricted agonism
por: Medler, Juliane, et al.
Publicado: (2022)

Tumor Necrosis Factor Induces Tumor Promoting and Anti-Tumoral Effects on Pancreatic Cancer via TNFR1
por: Chopra, Martin, et al.
Publicado: (2013)

A TNFR2-Specific TNF Fusion Protein With Improved In Vivo Activity
por: Vargas, Juan Gamboa, et al.
Publicado: (2022)

Targeting Regulatory T Cells by Addressing Tumor Necrosis Factor and Its Receptors in Allogeneic Hematopoietic Cell Transplantation and Cancer
por: Wajant, Harald, et al.
Publicado: (2019)

TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms
por: Rauert, H, et al.
Publicado: (2011)

The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy
por: Takahashi, Hiroyuki, et al.
Publicado: (2022)

Up-regulation of tumor necrosis factor-α pathway survival genes and of the receptor TNFR2 in gastric cancer
por: Rossi, Ana Flávia Teixeira, et al.
Publicado: (2019)

Expression of Tumor Necrosis Factor Receptor 2 Characterizes TLR9-Driven Formation of Interleukin-10-Producing B Cells
por: Ticha, Olga, et al.
Publicado: (2018)

Colitis-induced upregulation of tumor necrosis factor receptor-2 (TNFR2) terminates epithelial regenerative signaling to restore homeostasis
por: Sharifkhodaei, Zohreh, et al.
Publicado: (2023)

Impact of Tumor Necrosis Factor Receptor 1 (TNFR1) Polymorphism on Dry Eye Disease
por: Acuna, Kelly, et al.
Publicado: (2023)

TNFRSF receptor-specific antibody fusion proteins with targeting controlled FcγR-independent agonistic activity
por: Medler, Juliane, et al.
Publicado: (2019)

CD40- and CD95-specific antibody single chain-Baff fusion proteins display BaffR-, TACI- and BCMA-restricted agonism
por: Nelke, Johannes, et al.
Publicado: (2020)

Chronic Inflammation Increases the Sensitivity of Mouse Treg for TNFR2 Costimulation
por: Schmid, Tobias, et al.
Publicado: (2017)

Complement 1q/Tumor Necrosis Factor-Related Proteins (CTRPs): Structure, Receptors and Signaling
por: Schanbacher, Constanze, et al.
Publicado: (2023)

Plasma Levels of Soluble Tumor Necrosis Factor Receptor 2 (sTNFR2) Are Associated with Hippocampal Volume and Cognitive Performance in Patients with Schizophrenia
por: Kudo, Noriko, et al.
Publicado: (2018)

Association Study of Tumor Necrosis Factor Receptor 1 (TNFR1) Gene Polymorphisms with Schizophrenia in the Polish Population
por: Suchanek-Raif, Renata, et al.
Publicado: (2017)

Targeted killing of TNFR2-expressing tumor cells and T(regs) by TNFR2 antagonistic antibodies in advanced Sézary syndrome
por: Torrey, H, et al.
Publicado: (2018)

Brefeldin A-Inhibited Guanine Nucleotide-Exchange Factor 1 (BIG1) Governs the Recruitment of Tumor Necrosis Factor Receptor-Associated Factor 2 (TRAF2) to Tumor Necrosis Factor Receptor 1 (TNFR1) Signaling Complexes
por: Noguchi, Takuya, et al.
Publicado: (2016)

Transmembrane TNF and Its Receptors TNFR1 and TNFR2 in Mycobacterial Infections
por: Ruiz, Andy, et al.
Publicado: (2021)

TNF Receptor Associated Factor 2 (TRAF2) Signaling in Cancer
por: Siegmund, Daniela, et al.
Publicado: (2022)

Preclinical and clinical aspects of TNF-α and its receptors TNFR1 and TNFR2 in breast cancer
por: Martínez-Reza, Isela, et al.
Publicado: (2017)

Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy
por: Zaitseva, Olena, et al.
Publicado: (2022)

TARGETING TREG CELLS BY TNFR2 ANTIBODY INDUCES TUMOR REGRESSION IN VIVO
por: Yi, Zuoan David, et al.
Publicado: (2023)

Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity
por: Zaitseva, Olena, et al.
Publicado: (2023)

Targeting TNFR2 in Cancer: All Roads Lead to Rome
por: Bai, Jingchao, et al.
Publicado: (2022)

Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer
por: Li, Muchun, et al.
Publicado: (2022)

Membrane Tumor Necrosis Factor (TNF) Induced Cooperative Signaling of TNFR60 and TNFR80 Favors Induction of Cell Death Rather Than Virus Production in HIV-infected T Cells
por: Lazdins, Janis K., et al.
Publicado: (1997)

TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAP
por: Knop, Janin, et al.
Publicado: (2019)

Anti-inflammatory treatment in MPN: targeting TNFR1 and TNFR2 in JAK2-V617F–induced disease
por: Müller, Peter, et al.
Publicado: (2021)

Co-modulation of TNFR1 and TNFR2 in an animal model of multiple sclerosis
por: Fiedler, Timon, et al.
Publicado: (2023)

Correction: TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAP
por: Knop, Janin, et al.
Publicado: (2020)

Tumor necrosis factor receptor family costimulation increases regulatory T‐cell activation and function via NF‐κB
por: Lubrano di Ricco, Martina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tp517r9rjeoptvomroaklkncjb